Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: A cross-sectional study

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 837-842

  Gray, Laura J ^a   Tringham, Jennifer R ^b   Davies, Melanie J ^c   Webb, David R ^c   Jarvis, Janet ^c   Skinner, Timothy C ^d   Farooqi, Azhar M ^a   Khunti, Kamlesh ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b FRIMLEY PARK HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

Cardiovascular risk; Impaired glucose regulation; Screening; Type 2 diabetes

Indexed keywords

GLUCOSE;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; DYSLIPIDEMIA; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FAMILY HISTORY; FEMALE; GENERAL PRACTICE; GEOGRAPHIC ORIGIN; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL HISTORY; MULTIETHNIC POPULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PERIPHERAL VASCULAR DISEASE; POPULATION; PREGNANCY DIABETES MELLITUS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SOUTH ASIA; UNITED KINGDOM; CAUCASIAN; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; ETHNIC GROUP; ETHNOLOGY; GLUCOSE TOLERANCE TEST; INDIA; METHODOLOGY; MIDDLE AGED; RISK; STATISTICS;

ADULT; AGED; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE TOLERANCE TEST; GREAT BRITAIN; HUMANS; INDIA; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS;

EID: 79951864518     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S12504     Document Type: Article

References (30)

1. Diabetes UK. Diabetes in the UK 2010: key statistics on diabetes. 2010. Available from: http://www.diabetes.org.uk/Documents/Reports/Diabetes_in_the_UK_2010.pdf. Accessed on Aug 1, 2010.
2. Yorkshire and Humber Public Observatory. Phase 3 PBS Diabetes prevalence model 2008. Available from: http://www.yhpho.org.uk/viewResource. Accessed on Aug 1, 2010.
3. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992; 15(7):815-819.
4. UK Prospective Diabetes Study (UKPDS) VIII. Study design, progress and performance. Diabetologia. 1991;34:877-890.
5. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359(9324): 2140-2144.
6. Colagiuri S, Cull CA, Holman RR. Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? U.K. prospective diabetes study 61. Diabetes Care. 2002;25(8): 1410-1417.
7. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589.
8. DREAM (Diabetes REduction Assessment with ramipril and rosiglitazonem Medication) Trial Investigators.
9. Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet. 2006;368(9541):1096-1105.
10. Nathan DM. Navigating the choices for diabetes prevention. N Engl J Med. 2010;362:1533-1535.
11. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1): 155-161.
12. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22(2):233-240.
13. Waugh N, Scotland G, McNamee P, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess. 2007;11(17):3-4, ix-xi, 1-125.
14. Department of Health. National Screening Committee; first report of the National Screening Committee. London, UK: Health Departments of the United Kingdom; 1998.
15. Walker N, Gardiner E, Davies MJ, Khunti K. The NHS Health Checks programme: implications for delivery in primary care. Diabetes and Primary Care. 2009;11(4).
16. Department of Health. NHS Health Check Programme - Vascular Programme, putting prevention first. NHD Health Check: Vascular risk assessment and management. Best Practice Guidance. London, UK: Department of Health; 2009.
17. Riste L, Khan F, Cruickshank K. High prevalence of type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe?. Diabetes Care. 2001;24(8):1377-1383.
18. Forouhi NG, Merrick D, Goyder E, et al. Diabetes prevalence in England, 2001 - estimates from an epidemiological model. Diabet Med. 2006;23(2):189-197.
19. Mather HM, Chaturvedi N, Fuller JH. Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med. 1998;15(1):53-59.
20. Fischbacher CM, Bhopal R, Rutter MK, et al. Microal buminuria is more frequent in South Asian than in European origin populations: A comparative study in Newcastle, UK. Diabet Med. 2003;20(1):31-36.
21. Bhopal R, Fischbacher CM. Many South Asian people probably need pre-diabetes care. BMJ. 2002;325(7370):965-966.
22. Simmons D, Williams DRR, Powell MJ. Prevalence of diabetes in different regional and religious south Asian communities in Coventry. Diabet Med. 1992;9(5):428-431.
23. Vyas A, Haidery AZ, Wiles PG, Gill S, Roberts C, Cruickshank JK. A pilot randomized trial in primary care to investigate and improve knowledge, awareness and self-management among South Asians with diabetes in Manchester. Diabet Med. 2003;20(12):1022-1026.
24. Prineas R, Crow R, Blackburn H. The Minnesota Code Classification for Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Littleton, MA: John Wright; 1982.
25. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553.
26. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ. 2009;338:b880.
27. Health Survey for England. Health of ethnic minorities. 2004. Available from: http://www.ic.nhs.uk/pubs/hse04ethnic. Accessed on July 10,2010.
28. Simmons D, Williams DR, Powell MJ. The Coventry Diabetes study: prevalence of diabetes and impaired glucose tolerance in europids and asians. Q J Med. 1991;81(296):1021-1030.
29. Unwin N, Alberti KGMM, Bhopal R, Harland J, Watson W, White M. Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. Diabet Med. 1998;15(7):554-557.
30. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, et al. Different strategies for screening and prevention of type 2 diabetes in adults: Cost effectiveness analysis. BMJ. 2008;336(7654): 1180-1185.